Carbiotix Past Earnings Performance
Past criteria checks 0/6
Carbiotix's earnings have been declining at an average annual rate of -28.1%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been declining at an average rate of 0.6% per year.
Key information
-28.1%
Earnings growth rate
-9.7%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -0.6% |
| Return on equity | -72.2% |
| Net Margin | -313.9% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Carbiotix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -13 | 17 | 0 |
| 30 Sep 23 | 4 | -13 | 16 | 0 |
| 30 Jun 23 | 4 | -13 | 15 | 0 |
| 31 Mar 23 | 4 | -13 | 15 | 0 |
| 31 Dec 22 | 3 | -12 | 14 | 0 |
| 30 Sep 22 | 3 | -12 | 14 | 0 |
| 30 Jun 22 | 3 | -12 | 14 | 0 |
| 31 Mar 22 | 3 | -11 | 13 | 0 |
| 31 Dec 21 | 3 | -10 | 13 | 0 |
| 30 Sep 21 | 3 | -9 | 12 | 0 |
| 30 Jun 21 | 3 | -9 | 12 | 0 |
| 31 Mar 21 | 3 | -7 | 11 | 0 |
| 31 Dec 20 | 4 | -6 | 11 | 0 |
| 30 Sep 20 | 4 | -5 | 10 | 0 |
| 30 Jun 20 | 4 | -5 | 9 | 0 |
| 31 Mar 20 | 4 | -6 | 9 | 0 |
| 31 Dec 19 | 3 | -5 | 9 | 0 |
| 30 Sep 19 | 3 | -5 | 8 | 0 |
| 30 Jun 19 | 3 | -4 | 7 | 0 |
| 31 Mar 19 | 4 | -3 | 6 | 0 |
| 31 Dec 18 | 4 | -2 | 6 | 0 |
| 31 Dec 17 | 3 | -1 | 4 | 0 |
Quality Earnings: CRBX is currently unprofitable.
Growing Profit Margin: CRBX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRBX is unprofitable, and losses have increased over the past 5 years at a rate of 28.1% per year.
Accelerating Growth: Unable to compare CRBX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRBX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: CRBX has a negative Return on Equity (-72.17%), as it is currently unprofitable.